Gallium: The metal China doesn’t want you to have
Gallium’s captured the imagination since China restricted exports, but what is it and which ASX companies are in line to become producers?
Stockhead
US fundies take bull thesis Down Under
How undervalued are commodities and mining and energy stocks? These fund managers think they’re at 150-year lows, and see a new bull run on the horizon.
These junior goldies are on the majors’ radars
Big miners are always hunting growth. Leeuwin Metals and Tesoro Gold are two gold juniors with monsters lurking on their registers.
Arika hits deeper gold at Yundamindra
Arika has risen as much as 56% on high-grade results from Yundamindra as gold bounces back above $3000.
Sponsored Content
Road to 2025: Trajan’s plans for growth and expansion
Tylah Tully looks at Trajan Group’s achievements in 2024, and big plans for the company this year.
Animoca Brands’ subsidiary GAMEE reveals web3 game Moon Cards
Animoca Brands’ subsidiary GAMEE has launched a web3-based trading card game, Moon Cards, powered by memecoins.
VHM on track for Goschen FID
The mining licence puts VHM on track for a final investment decision on the Goschen rare earths and mineral sands project this year.
StockTake: Caprice Resources
Caprice Resources has signed a drill-for-equity agreement with Topdrill for exploration across its Murchison projects.
Health Kick Podcast: Arovella Therapeutics
In this episode, Tim sits down with Arovella Therapeutics to discuss the company’s pipeline and what it has been working on.
Long Shortz: Green Technology Metals
Tylah Tully speaks with Green Technology Metals (ASX:GT1) managing director Cameron Henry about the company’s updated PEA for its Root lithium project in Ontario, Canada.
More Stories
Sunshine has golden glow for big name investor
At Lion Selection Group, Hedley Widdup is at the helm of one of Australia’s top junior gold investors. Here’s where Lion is upping its stake.
Orthocell is off and running in the US nerve-repair market
Having won US Food & Drug Administration approval for its novel nerve repair agent Remplir, Orthocell is wasting no time in getting it to market.
Predator and Prey: QEM Limited
Predator and Prey analyses emerging explorers and why they might attract acquisition interest. This time we’re looking at QEM Limited.
ASX stocks await US manufacturing drive
Trump’s ‘Liberation Day’ movement has hammered equities, but these ASX stocks are positioning for a US manufacturing boom.
Saskatchewan’s minerals more valued than ever
With critical minerals becoming ever more important, Saskatchewan has all the right ingredients to be a major player.
An ASX copper stock’s potential unearthed
Queensland copper junior QMines has achieved a lot in its almost four years on the ASX – though its market capitalisation doesn’t reflect that.
Is antimony’s sell-off overdone?
Antimony stocks weren’t saved from the recent market carnage. But prices are at all time highs and advanced players are now looking cheap.
Seven reasons why everything will be OK
In the spirit of hopeless optimism, here are seven reasons why Australia could fare well in the redux world of tariff protectionism.
Gold: Cool in a crisis
If it feels like the global economy is burning that could be a hint that gold equities are about to outperform again.
Legacy higher on robust Drake gold study
Legacy Minerals has returned a robust scoping study for the Drake project as investors continue to move into gold.
Gold soars and oil plunges, ASX falls 0.82pc
The ASX has dipped 0.82pc in trading today, while gold soared to record new highs above US$3,200 per ounce and oil fell to levels not seen since March 2020.
ASX health stocks fall in roller coaster week
ASX health stocks fall with Morgans Scott Power noting Trump’s on-again, off-again Liberation Tariffs sending shock waves through markets.
Tariffs hit mining stocks
Tariffs on Chinese goods could bring risks for commodity demand, as Goldman Sachs warns on iron ore, coal and alumina.
ASX drops 1pc as Wall Street panics, gold soars
As markets tanks and Wall Street loses the plot, investors pile into gold, and Ramsay Healthcare shakes up the top deck.
Break it Down: Legacy Minerals
Tylah Tully digs into Legacy Minerals and a Stage 1 Scoping Study which outlined its 32koz+ annual gold production potential.
ASX falls as markets navigate stormy waters
The ASX will once again follow US markets down today, falling 2pc in early trading as tech, healthcare and energy stocks take the brunt. Europe bucked the trend, gaining more than 3pc.
Resources stocks stand strong amid market chaos
Resources stocks showed few signs of weakness at this years Resources Rising Stars Gather round conference amid market turmoil.
The silver lining for gold in tariffs
Trump’s tariffs may have throttled the market, but gold miners are riding high with bullion prices at a record and oil crashing.
ASX jumps 4.5pc as EU levels tariffs on US
While the ASX is up 4.5pc and the tech sector 7pc as Trump pauses the majority of tariffs for 90 days, the EU’s own tariff measures released overnight could reignite tensions.
What does the market volatility mean for ASX small caps?
Stockhead asked five stocks at the Resources Rising Stars conference how they are positioned to navigate the current market uncertainty.
FME moves into high-gear in the Kimberley
Future Metals could process ore from its Eileen Bore and Panton deposits at Zeta Resources’ Savannah nickel processing plant.
ZNC lands drilling grant for Red Mountain
Zenith Minerals has won a $275,000 grant from the Queensland Government to drill deeper at the Red Mountain gold project.
Arika hits more Laverton gold
Arika Resources hits more high grade gold as the Pennyweight Point discovery at Yundamindra project near Laverton gets deeper and richer.
NAE eyes Hemi-style gold at Wagyu
New Age Exploration has wrapped up its maiden RC drilling program at the Wagyu gold project in WA.
BTR flags high-grade gold in aggressive WA exploration campaign
Brightstar Resources has reported up to 75.5g/t gold at the Vanguard North deposit at its Sandstone hub in WA.
Audeara aims to reshape hearing tech
Audeara and its CEO Dr James Fielding aim to revolutionise hearing tech with personalised solutions and global partnerships.
Original URL: https://www.theaustralian.com.au/business/stockhead